Senior government sources confirmed the impending announcement to CTV News.
Health Minister Jean-Yves Duclos is scheduled to hold a press conference at 2 p.m., which will “underline the importance of vaccination against COVID-19 as we approach autumn,” according to a media release.
Health Canada received Moderna’s application for its bivalent vaccine on June 30. A bivalent vaccine would provide protection against the original strain of COVID-19 and Omicron subvariants. The federal regulator is also reviewing Pfizer-BioNTech’s application, which was filed on July 25.
Dr. Theresa Tam, Canada’s public health chief, has previously said the country has secured an “adequate” supply of bivalent vaccines if regulators give the go-ahead for development.
Earlier this month, the UK became the first in the world to approve Moderna’s bivalent vaccine. On Wednesday, the US Food and Drug Administration approved its first bivalent vaccines for COVID-19.
Experts expect another wave of the COVID-19 pandemic to hit this fall as temperatures drop and more people gather indoors.
While the benefits of bivalent vaccines are still being studied, emerging research suggests they could offer extended protection compared to currently available COVID-19 vaccines.
– with files from The Canadian Press and The Associated Press
title: “Covid 19 Moderna S Bivalent Vaccine To Be Approved In Canada Klmat”
ShowToc: true
date: “2022-12-12”
author: “Matthew Drake”
Senior government sources confirmed the impending announcement to CTV News.
Health Minister Jean-Yves Duclos is scheduled to hold a press conference at 2 p.m., which will “underline the importance of vaccination against COVID-19 as we approach autumn,” according to a media release.
Health Canada received Moderna’s application for its bivalent vaccine on June 30. A bivalent vaccine would provide protection against the original strain of COVID-19 and Omicron subvariants. The federal regulator is also reviewing Pfizer-BioNTech’s application, which was filed on July 25.
Dr. Theresa Tam, Canada’s public health chief, has previously said the country has secured an “adequate” supply of bivalent vaccines if regulators give the go-ahead for development.
Earlier this month, the UK became the first in the world to approve Moderna’s bivalent vaccine. On Wednesday, the US Food and Drug Administration approved its first bivalent vaccines for COVID-19.
Experts expect another wave of the COVID-19 pandemic to hit this fall as temperatures drop and more people gather indoors.
While the benefits of bivalent vaccines are still being studied, emerging research suggests they could offer extended protection compared to currently available COVID-19 vaccines.
– with files from The Canadian Press and The Associated Press